Search results
1 kwi 2024 · More evidence now supports the treatment of superficial vein thrombosis with anticoagulation in high-risk patients. 1. In this article, we review risk factors, supportive management, choice of anticoagulation therapy, and treatment considerations in special patient populations.
2 paź 2020 · For patients with uncomplicated deep vein thrombosis (DVT), the American Society of Hematology (ASH) guideline panel suggests offering home treatment over hospital treatment (conditional recommendation based on low certainty in the evidence of effects ⨁⨁ ).
5 lis 2017 · Understanding the age of the thrombus will allow physicians to balance the benefits and risks of treatment, as well as the likelihood of treatment success. Pharmaceutical advances and recent evidence regarding the biology of thrombi are changing clinical practice.
4 wrz 2024 · The mainstay of therapy for DVT is anticoagulation, provided there is no contraindication. Thrombolysis is occasionally needed. An overview of the treatment of lower extremity DVT (distal and proximal), including treatment of special populations of patients with DVT, is discussed in this topic.
8 paź 2020 · For patients with proximal DVT and significant pre-existing cardiopulmonary disease as well as patients with PE and hemodynamic compromise, the ASH guidelines suggest anticoagulation alone over anticoagulation plus inferior vena cava (IVC) filter placement.
An incomplete occlusion indicates that there is some flow of blood around the clot, and whether that flow could dislodge the clot. Conversely, a completely occlusive clot may indicate a higher thrombus load and thus confer a higher risk of PE.
26 mar 2020 · This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE).
